Prostate Cancer Brachytherapy: What You Need To Know

Prostate Brachytherapy: Overview, Types, and Purpose

Prostate brachytherapy is a form of radiation therapy used in the treatment of prostate cancer. This method involves placing tiny radioactive seeds inside the prostate gland.

There are two types of prostate brachytherapy: permanent (low-dose rate or LDR) and temporary (high-dose rate or HDR).

The permanent type consists of small radioactive seeds that are implanted into the prostate, where they remain, gradually releasing radiation over several months.
The temporary type involves the insertion of stronger radioactive material for brief periods before it is removed.

This treatment is designed to target cancer cells while minimizing damage to healthy cells, thereby potentially reducing side effects and potentially improving the quality of life during recovery. It is considered an option for those with early-stage prostate cancer.

Prostate brachytherapy is a subject of discussion in the context of treatment options for early-stage prostate cancer.

Potential Side Effects and Risks of Prostate Brachytherapy

Prostate brachytherapy, a type of radiation therapy, is used to treat prostate cancer. This treatment carries its own set of potential side effects and risks.

Urinary problems are common after the procedure, which may include discomfort while urinating or an increased frequency of urination.
Bowel issues, such as diarrhea or rectal bleeding, can also occur.
Some patients report experiencing fatigue after treatment, often referred to as radiation fatigue.
Sexual dysfunction is another potential side effect, with some men experiencing changes in their ability to have an erection (erectile dysfunction).

It is important to recognize that individual responses to treatment can vary. The severity and duration of these side effects differ from person to person.

Find Top Cancer Clinical Trials

Choose from over 30,000 active clinical trials.

Preparation and Procedures for Prostate Brachytherapy: LDR and HDR

Preparation for prostate brachytherapy begins with a consultation and includes a physical exam. Imaging tests such as MRI or CT scans are also part of the preparatory steps.

Prior to the surgery, patients are required to refrain from eating and drinking from midnight on the day of the procedure to prepare for anesthesia and to ensure the safety of the surgery.

LDR, or Low Dose Rate brachytherapy, involves the placement of small radioactive seeds in the prostate gland. These seeds emit radiation over several months. The procedure includes the insertion of needles through the perineum to guide radioactive seeds into the prostate gland.
HDR, or High Dose Rate brachytherapy, uses temporary radioactive sources to deliver a high dose of radiation in a short amount of time. This process involves inserting thin tubes, or catheters, through small incisions into the prostate gland under ultrasound guidance. A machine then sends concentrated radiation through these tubes to the cancer cells.

Both methods are designed to target cancer cells while minimizing exposure to surrounding healthy tissues. Recovery times vary, with normal activities typically resuming after a few days depending on the individual's recuperation.

Post-Procedure Expectations and Monitoring Treatment Success

After a clinical trial procedure, side effects may occur, varying from person to person. Common ones include fatigue, pain, or changes in appetite, while some trials may cause rare but severe reactions. The medical team monitors these closely.

Monitoring treatment success is a critical component, involving regular check-ups and tests. This may include:

Blood tests
Scans
Physical exams

to assess the effectiveness of the treatment.

The improvement of the health condition typically signals successful treatment, though it can be complex due to the experimental nature of clinical trials.

Understanding post-procedure expectations and monitoring progress are part of the process.

Staying informed about every step of the journey is beneficial.

Managing Rising PSA Levels after Brachytherapy

Managing rising PSA levels after brachytherapy is crucial. Brachytherapy or internal radiation therapy is a common treatment for prostate cancer. It involves placing radioactive seeds in the prostate gland to kill cancer cells.

After this procedure, Prostate-Specific Antigen (PSA) levels may rise temporarily. This spike is often attributed to a non-cancerous condition called "benign prostatic hyperplasia" (BPH). BPH leads to an enlarged prostate, which can elevate PSA levels.

Regular monitoring of PSA levels post-brachytherapy is key in managing its increase. A continuous elevation might indicate recurrent or persistent disease. In such scenarios, additional treatments like hormone therapy, chemotherapy, cryotherapy, or surgery might be necessary.

Early detection is associated with more options for effective treatment.